Gene · 3036
Papers4,320
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 4,320
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Has-miR-199a-3p/RELA/SCD inhibits immune checkpoints in AMD and promotes macrophage-mediated inflammation and pathological angiogenesis through lipid metabolism pathway: A computational analysis. | PLoS One | 2024 | 38625951 | PubTator, text mining | PubMed |
| Chemoenzymatic Synthesis of Tri-antennary N-Glycans Terminating in Sialyl-Lewisx Reveals the Importance of Glycan Complexity for Influenza A Virus Receptor Binding. | Chemistry | 2024 | 38567703 | PubTator, text mining | PubMed |
| Movement-goal relevant object shape properties act as poor but viable cues for the attribution of motor errors to external objects. | PLoS One | 2024 | 38547216 | PubTator, text mining | PubMed |
| AβPP-tau-HAS1 axis trigger HAS1-related nuclear speckles and gene transcription in Alzheimer's disease. | Matrix Biol | 2024 | 38518923 | PubTator, text mining | PubMed |
| Effect of sulfuric acid hydrolysis on the structure and Pickering emulsifying capacity of acorn starch. | Food Chem X | 2024 | 38515830 | PubTator, text mining | PubMed |
| Lovastatin impairs cellular proliferation and enhances hyaluronic acid production in fibroblast-like synoviocytes. | Toxicol In Vitro | 2024 | 38432573 | PubTator, text mining | PubMed |
| Global analysis of urinary extracellular vesicle small RNAs in autosomal dominant polycystic kidney disease. | J Gene Med | 2024 | 38404150 | PubTator, text mining | PubMed |
| IGF2BP3 loss inhibits cell progression by upregulating has_circRNA_103820, and hsa_circRNA_103820-encoded peptide inhibits cell progression by inactivating the AKT pathway in lung cancer. | Chem Biol Drug Des | 2024 | 38378275 | PubTator, text mining | PubMed |
| The Superior Effect of Radiofrequency With Targeted Ultrasound for Facial Rejuvenation by Inducing Hyaluronic Acid Synthesis: A Pilot Preclinical Study. | Aesthet Surg J Open Forum | 2024 | 38371657 | PubTator, text mining | PubMed |
| Editorial: Emerging talents in toxicology. | Front Toxicol | 2024 | 38362109 | PubTator, text mining | PubMed |
| Actinidia polygama Water Extract (APWE) Protects Against UVB-Induced Photoaging via MAPK/AP-1 and TGFβ-Smad Pathway. | Ann Dermatol | 2024 | 38325430 | PubTator, text mining | PubMed |
| Guanidine dicycloamine-based analogs: green chemistry synthesis, biological investigation, and molecular docking studies as promising antibacterial and antiglycation leads. | Mol Divers | 2024 | 38324159 | PubTator, text mining | PubMed |
| ANKRD1 is a mesenchymal-specific driver of cancer-associated fibroblast activation bridging androgen receptor loss to AP-1 activation. | Nat Commun | 2024 | 38310103 | PubTator, text mining | PubMed |
| Modern techniques in addressing facial acne scars: A thorough analysis. | Skin Res Technol | 2024 | 38303407 | PubTator, text mining | PubMed |
| Lespedeza maximowiczii flower absolute promotes skin epithelization, barrier properties, and moisturization-related beneficial responses in human keratinocytes. | Heliyon | 2024 | 38293355 | PubTator, text mining | PubMed |
| Risk scores for major bleeding from direct oral anticoagulants: comparing predictive performance in patients with atrial fibrillation. | Res Pract Thromb Haemost | 2024 | 38292348 | PubTator, text mining | PubMed |
| Protective effect of Bifidobacterium animalis CGMCC25262 on HaCaT keratinocytes. | Int Microbiol | 2024 | 38278974 | PubTator, text mining | PubMed |
| Immunoregulatory Roles of Osteopontin in Diseases. | Nutrients | 2024 | 38276550 | PubTator, text mining | PubMed |
| Recent Developments in Nanoparticle Formulations for Resveratrol Encapsulation as an Anticancer Agent. | Pharmaceuticals (Basel) | 2024 | 38256959 | PubTator, text mining | PubMed |
| The Clinical Utility of the Saliva Proteome in Rare Diseases: A Pilot Study for Biomarker Discovery in Primary Sclerosing Cholangitis. | J Clin Med | 2024 | 38256678 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3036/papers?page=8